These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

364 related items for PubMed ID: 10696105

  • 1. Postsynaptic 5-hydroxytryptamine(1A) receptor activation increases in vivo dopamine release in rat prefrontal cortex.
    Sakaue M, Somboonthum P, Nishihara B, Koyama Y, Hashimoto H, Baba A, Matsuda T.
    Br J Pharmacol; 2000 Mar; 129(5):1028-34. PubMed ID: 10696105
    [Abstract] [Full Text] [Related]

  • 2. MKC-242, a novel 5-HT1A receptor agonist, facilitates cortical acetylcholine release by a mechanism different from that of 8-OH-DPAT in awake rats.
    Somboonthum P, Matsuda T, Asano S, Sakaue M, Baba A.
    Neuropharmacology; 1997 Mar; 36(11-12):1733-9. PubMed ID: 9517445
    [Abstract] [Full Text] [Related]

  • 3. Increase of noradrenaline release in the hypothalamus of freely moving rat by postsynaptic 5-hydroxytryptamine1A receptor activation.
    Suzuki M, Matsuda T, Asano S, Somboonthum P, Takuma K, Baba A.
    Br J Pharmacol; 1995 Jun; 115(4):703-11. PubMed ID: 7582494
    [Abstract] [Full Text] [Related]

  • 4. Behavioral and neurochemical effects of 5-(4-[4-(5-Cyano-3-indolyl)-butyl)-butyl]-1-piperazinyl)-benzofuran-2-carboxamide (EMD 68843): a combined selective inhibitor of serotonin reuptake and 5-hydroxytryptamine(1A) receptor partial agonist.
    Page ME, Cryan JF, Sullivan A, Dalvi A, Saucy B, Manning DR, Lucki I.
    J Pharmacol Exp Ther; 2002 Sep; 302(3):1220-7. PubMed ID: 12183683
    [Abstract] [Full Text] [Related]

  • 5. Interaction of orally administered 5-[3-[((2S)-1,4-benzodioxan-2-ylmethyl)amino]propoxy]-1,3-benzodioxole (MKC-242) with 5-HT1A receptors in rat brain.
    Asano S, Matsuda T, Yoshikawa T, Somboonthum P, Tasaki H, Abe M, Baba A.
    Jpn J Pharmacol; 1997 May; 74(1):69-75. PubMed ID: 9195299
    [Abstract] [Full Text] [Related]

  • 6. Extended action of MKC-242, a selective 5-HT(1A) receptor agonist, on light-induced Per gene expression in the suprachiasmatic nucleus in mice.
    Takahashi S, Yoshinobu Y, Aida R, Shimomura H, Akiyama M, Moriya T, Shibata S.
    J Neurosci Res; 2002 May 15; 68(4):470-8. PubMed ID: 11992474
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Tandospirone potentiates the fluoxetine-induced increases in extracellular dopamine via 5-HT(1A) receptors in the rat medial frontal cortex.
    Yoshino T, Nisijima K, Katoh S, Yui K, Nakamura M.
    Neurochem Int; 2002 Apr 15; 40(4):355-60. PubMed ID: 11792466
    [Abstract] [Full Text] [Related]

  • 9. Selective reduction by isolation rearing of 5-HT1A receptor-mediated dopamine release in vivo in the frontal cortex of mice.
    Ago Y, Sakaue M, Baba A, Matsuda T.
    J Neurochem; 2002 Oct 15; 83(2):353-9. PubMed ID: 12423245
    [Abstract] [Full Text] [Related]

  • 10. R(+)-8-OH-DPAT, a serotonin(1A) receptor agonist, potentiated S(-)-sulpiride-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens but not striatum.
    Ichikawa J, Meltzer HY.
    J Pharmacol Exp Ther; 1999 Dec 15; 291(3):1227-32. PubMed ID: 10565846
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. 5-HT(2A) and D(2) receptor blockade increases cortical DA release via 5-HT(1A) receptor activation: a possible mechanism of atypical antipsychotic-induced cortical dopamine release.
    Ichikawa J, Ishii H, Bonaccorso S, Fowler WL, O'Laughlin IA, Meltzer HY.
    J Neurochem; 2001 Mar 15; 76(5):1521-31. PubMed ID: 11238736
    [Abstract] [Full Text] [Related]

  • 13. Preferential in vivo action of F15599, a novel 5-HT(1A) receptor agonist, at postsynaptic 5-HT(1A) receptors.
    Lladó-Pelfort L, Assié MB, Newman-Tancredi A, Artigas F, Celada P.
    Br J Pharmacol; 2010 Aug 15; 160(8):1929-40. PubMed ID: 20649591
    [Abstract] [Full Text] [Related]

  • 14. 8-OH-DPAT influences extracellular levels of serotonin and dopamine in the medial preoptic area of male rats.
    Lorrain DS, Matuszewich L, Hull EM.
    Brain Res; 1998 Apr 20; 790(1-2):217-23. PubMed ID: 9593901
    [Abstract] [Full Text] [Related]

  • 15. Neurochemical evaluation of the novel 5-HT1A receptor partial agonist/serotonin reuptake inhibitor, vilazodone.
    Hughes ZA, Starr KR, Langmead CJ, Hill M, Bartoszyk GD, Hagan JJ, Middlemiss DN, Dawson LA.
    Eur J Pharmacol; 2005 Mar 07; 510(1-2):49-57. PubMed ID: 15740724
    [Abstract] [Full Text] [Related]

  • 16. 5-HT(1A) and 5-HT(2A) receptors minimally contribute to clozapine-induced acetylcholine release in rat medial prefrontal cortex.
    Ichikawa J, Dai J, Meltzer HY.
    Brain Res; 2002 Jun 07; 939(1-2):34-42. PubMed ID: 12020849
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Activation of 5-HT(1B/1D) receptors in the mesolimbic dopamine system increases dopamine release from the nucleus accumbens: a microdialysis study.
    Yan QS, Yan SE.
    Eur J Pharmacol; 2001 Apr 20; 418(1-2):55-64. PubMed ID: 11334865
    [Abstract] [Full Text] [Related]

  • 19. Characterization of endogenous serotonin-mediated regulation of dopamine release in the rat prefrontal cortex.
    Matsumoto M, Togashi H, Mori K, Ueno K, Miyamoto A, Yoshioka M.
    Eur J Pharmacol; 1999 Oct 21; 383(1):39-48. PubMed ID: 10556679
    [Abstract] [Full Text] [Related]

  • 20. Role of postsynaptic serotonin1A receptors in risperidone-induced increase in acetylcholine release in rat prefrontal cortex.
    Sato M, Ago Y, Koda K, Nakamura S, Kawasaki T, Baba A, Matsuda T.
    Eur J Pharmacol; 2007 Mar 22; 559(2-3):155-60. PubMed ID: 17258195
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.